Role of liver cancer stem cells in hepatocellular carcinoma and related strategies for targeted therapy
- VernacularTitle:肝癌干细胞在肝细胞癌中的作用和靶向治疗策略
- Author:
Wenting CUI
1
;
Ningning LIU
1
;
Xiuzhen MA
2
;
Ping MAI
3
Author Information
- Publication Type:Review
- Keywords: Neoplastic Stem Cells; Carcinoma， Hepatocellular; Tumor Microenvironment; Immunotherapy
- From: Journal of Clinical Hepatology 2026;42(2):457-463
- CountryChina
- Language:Chinese
- Abstract: Hepatocellular carcinoma （HCC） is a malignant tumor with relatively high incidence and mortality rates worldwide， and its therapeutic resistance and recurrence mechanism are closely associated with liver cancer stem cells （LCSC）. This article systematically introduces the biological characteristics of LCSC and their key role in the progression of HCC， reviews the functional characteristics of the specific surface markers （such as EpCAM and CD133） and related signaling pathways （such as Wnt/β-catenin， TGF-β， and STAT3）， elaborates on the interaction between LCSC and tumor microenvironment， and summarizes the latest clinical treatment strategies targeting LCSC and the countermeasure for existing resistance mechanisms. The article points out that LCSC promote tumor development and progression through metabolic reprogramming and immune microenvironment remodeling， and it is proposed to establish a standardized detection system for LCSC specific markers and promote a triple synergistic therapeutic paradigm combining targeted therapy， immune regulation， and traditional chemotherapy， in order to provide new ideas for the clinical intervention of HCC.
